The pandemic has shown the importance of collaboration and that individual actors cannot solve the health problems of today alone
In Conversation
Francis Van Parys, vice president commercial Asia-Pacific at Cytiva, a global life sciences leader dedicated to advancing and accelerating therapeutics, highlights the firm's tireless work to…
The Turkish authorities have chosen, in many cases, a PPP model where private investors come in and run the hospitals. The entire clinical piece remained with…
Companies should consider going beyond and investing in R&D localization in Turkey; they will be surprised by the potential
Big and specialized hospitals in Denmark such as ours are in a unique position to continue conducting clinical trials due to the relatively high number of…
In the last couple of years, the Scandinavian life science industry has rapidly opened up and is now very willing to engage with society more broadly.…
CAR-T is not necessarily the best treatment option for everyone. There could be other second-best options for a certain group of patients. Our point of view…
Our success can be attributed to one word: focus
The new structure allows us to work more closely with our customers. The CDMO landscape has been transformed in the last 5-10 years; cooperation and partnerships…
Our products create real value for patients, saving lives or radically improving their quality of life, but they need to be available for them
The most important milestone achieved by GEN happened this year, when the company became public, listing its stock on the Istanbul Stock Exchange. Although it is…
The strategy we put in place was to revitalise and refresh Lundbeck’s pipeline, which is our path to the future, in the short-, medium-, and long-term
